BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19496078)

  • 1. Trichotillomania in youth: a retrospective case series.
    Mancini C; Van Ameringen M; Patterson B; Simpson W; Truong C
    Depress Anxiety; 2009; 26(7):661-5. PubMed ID: 19496078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review.
    Rothbart R; Stein DJ
    Expert Opin Pharmacother; 2014 Dec; 15(18):2709-19. PubMed ID: 25399534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity in trichotillomania (hair-pulling disorder): A cluster analytical approach.
    Lochner C; Keuthen NJ; Curley EE; Tung ES; Redden SA; Ricketts EJ; Bauer CC; Woods DW; Grant JE; Stein DJ
    Brain Behav; 2019 Dec; 9(12):e01456. PubMed ID: 31692297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating trichotillomania: a meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors.
    McGuire JF; Ung D; Selles RR; Rahman O; Lewin AB; Murphy TK; Storch EA
    J Psychiatr Res; 2014 Nov; 58():76-83. PubMed ID: 25108618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulse control disorders in patients with obsessive-compulsive disorder.
    Fontenelle LF; Mendlowicz MV; Versiani M
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):30-7. PubMed ID: 15679537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichotillomania and obsessive-compulsive disorder.
    Stein DJ; Simeon D; Cohen LJ; Hollander E
    J Clin Psychiatry; 1995; 56 Suppl 4():28-34; discussion 35. PubMed ID: 7713862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series.
    Van Ameringen M; Mancini C; Patterson B; Bennett M
    Depress Anxiety; 2006; 23(1):1-5. PubMed ID: 16178009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characterization and treatment of trichotillomania.
    Christenson GA; Crow SJ
    J Clin Psychiatry; 1996; 57 Suppl 8():42-7; discussion 48-9. PubMed ID: 8698680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Treatment of Trichotillomania (Hair-Pulling Disorder), Excoriation (Skin-picking) Disorder, and Nail-biting (Onychophagia).
    Sani G; Gualtieri I; Paolini M; Bonanni L; Spinazzola E; Maggiora M; Pinzone V; Brugnoli R; Angeletti G; Girardi P; Rapinesi C; Kotzalidis GD
    Curr Neuropharmacol; 2019; 17(8):775-786. PubMed ID: 30892151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder.
    Masi G; Pfanner C; Millepiedi S; Berloffa S
    J Clin Psychopharmacol; 2010 Dec; 30(6):688-93. PubMed ID: 21105283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe obsessive-compulsive disorder with and without comorbid hair pulling: comparisons and clinical implications.
    Stewart SE; Jenike MA; Keuthen NJ
    J Clin Psychiatry; 2005 Jul; 66(7):864-9. PubMed ID: 16013902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases.
    Epperson CN; Fasula D; Wasylink S; Price LH; McDougle CJ
    J Child Adolesc Psychopharmacol; 1999; 9(1):43-9. PubMed ID: 10357517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Mohr N; Vythilingum B; Emsley RA; Stein DJ
    Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
    McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
    Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.
    Denys D; de Geus F; van Megen HJ; Westenberg HG
    J Clin Psychiatry; 2004 Aug; 65(8):1040-8. PubMed ID: 15323587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
    Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
    Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder and comorbid trichotillomania: a preliminary report.
    Golubchik P; Sever J; Weizman A; Zalsman G
    Clin Neuropharmacol; 2011; 34(3):108-10. PubMed ID: 21586916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of comorbid eating disorders and association with other obsessive-compulsive spectrum disorders in trichotillomania.
    Greenberg E; Grant JE; Curley EE; Lochner C; Woods DW; Tung ES; Stein DJ; Redden SA; Scharf JM; Keuthen NJ
    Compr Psychiatry; 2017 Oct; 78():1-8. PubMed ID: 28667830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.